Join Jonathan Boyers, Head of Alvarez & Marsal Corporate Finance, and Chris Maguire, Executive Editor of BusinessCloud, as they sit down to interview Matt Hirst, CEO of ESG.

As the U.S. considers imposing tariffs on European pharmaceutical imports, the ripple effects could be felt across the global healthcare landscape. For an industry already grappling with rising R&D costs and competitive pressures, these tariffs threaten to erode profit margins and disrupt finely tuned supply chains.

Learn why early consideration of transfer pricing in cross-border or multi-jurisdictional M&As can unlock value and mitigate risk.

Managing Directors Annie Peabody and Ron Orsini recently featured in NACD’s article, “What Is a Total Equity Story, and Why Does It Matter?”